Fibrosis: Clinical Trials

82 trials for Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

82 unknown. 82 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 482Unknown 82

Follow Fibrosis: new trials by email Literature Review of Fibrosis trials Research Report on Fibrosis

Trials (filtered) newest first · largest first

All 82 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule
Babaodan Capsule - Primary Biliary Cholangitis
Phase 4UnknownMei Han602024-04-252024-04-17
Efficacy and Durability of Hepatitis A Vaccination in Patients With Advanced Fibrosis and Cirrhosis
HAVRIX - Cirrhosis, Hep A
Phase 4UnknownMahidol University502024-02-292024-03-19
Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy
Polyethylene Glycols, Lactulose oral solution, L-ornithine L-aspartate - Hepatic Encephalopathy Stage 2, Hepatic Encephalopathy Stage 3
Phase 4UnknownJinnah Postgraduate Medical Centre3602023-10-012023-07-13
Efficacy and Safety of SOF/VEL + RBV and SOF/VEL/VOX for 12 Weeks in HCV Subjects With GT3b and Compensated Cirrhosis
Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir - Hepatitis C, Cirrhosis
Phase 4UnknownPeking University People's Hospital1002022-09-012022-07-21
Bleomycin Jet Injections in Keloids
Bleomycin, Normal saline - Keloid
Phase 4UnknownErasmus Medical Center142022-03-182022-11-09
A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
Methylprednisolone and Mycophenolate mofetil, Methylprednisolone and azathioprine - Autoimmune Hepatitis, Primary Biliary Cirrhosis
Phase 4UnknownXiaoli Fan782021-06-162021-06-21
Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
Cyclosporin A, Mycophenolate Mofetil - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital892021-06-162021-06-22
Avatrombopaq In Patients With Cirrhosis
Doptelet Pill - Thrombocytopenia; Drugs, Cirrhosis, Liver
Phase 4UnknownHvidovre University Hospital202021-06-012021-04-15
PBC Induced Fatigue Treated With Thiamine
Thiamine, Placebo - Primary Biliary Cirrhosis
Phase 4UnknownHenning Grønbæk362021-05-122021-05-20
Colchicine and Post-COVID-19 Pulmonary Fibrosis
Colchicine 0.5 MG, the standard protocol only - Covid19, Pulmonary Fibrosis Interstitial
Phase 4UnknownClinAmygate2602021-03-252023-09-06
Ursodeoxycholic Acid Combined With Total Glucosides of Paeony in the Treatment of PBC With AIH Features 1
Ursodeoxycholic acid combined with total glucosides of paeony, Ursodeoxycholic acid only - Hepatitis, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital1372021-03-172021-03-24
Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging
Gadodiamide, Gadoteric Acid Meglumine Salt - Nephrogenic Fibrosing Dermopathy
Phase 4UnknownThe Central Hospital of Lishui City6002021-03-012021-03-01
HBsAg Seroclearance in Adults With HBV Related Liver Fibrosis After Receiving Combined Therapy of Peg-IFN and Tenofovir.
PEG-Interferon Alfa, Tenofovir Disoproxil Fumarate, Tenofovir Disoproxil Fumarate - Liver Fibrosis
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University3362021-01-012024-01-26
Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.
Canrenoate Potassium, Normal Saline - COVID-19 Pneumonia
Phase 4UnknownPomeranian Medical University Szczecin502021-01-012021-06-08
Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
Ursodeoxycholic acid, Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) - Hepatitis, Autoimmune, Primary Biliary Cholangitis
Phase 4UnknownWest China Hospital902020-11-012021-03-22
Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes
Pioglitazone 15 Mg Oral Tablet, Evogliptin 5mg - Hepatitis B, Chronic, Fibrosis, Liver
Phase 4UnknownSeung Up Kim282020-09-182022-07-26
A Prospective Study of Tocilizumab in the Treatment of Idiopathic Retroperitoneal Fibrosis
Tocilizumab, Glucocorticoids - Idiopathic Retroperitoneal Fibrosis
Phase 4UnknownPeking Union Medical College Hospital402020-07-012021-03-22
A Prospective Study of Cyclophosphamide Treatment for Idiopathic Retroperitoneal Fibrosis
Cyclophosphamide and glucocorticoids, Glucocorticoids - Idiopathic Retroperitoneal Fibrosis
Phase 4UnknownPeking Union Medical College Hospital402020-01-032021-03-19
Bleomycin Infusion (MMP®) to Repigment Achromic Scars
Bleomycin, Saline Solution - SCAR
Phase 4UnknownClinica Dermatologica Arbache ltda502019-08-312019-08-06
TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)
Tenofovir Alafenamide - Hepatitis B, Fibrosis and Cirrhosis of Liver
Phase 4UnknownKaohsiung Medical University Chung-Ho Memorial Hospital802019-02-252019-04-26

Showing 20 of 82. Sign in to see all of them.

Narrower conditions

Liver Cirrhosis (27)  ·  Hypertension, Portal (8)  ·  Liver Cirrhosis, Biliary (7)  ·  Hepatitis B (5)  ·  Hepatitis B, Chronic (5)  ·  Pulmonary Fibrosis (5)  ·  Ascites (3)  ·  Cicatrix (3)  ·  Diabetes Mellitus, Type 2 (3)  ·  Esophageal Diseases (3)  ·  Esophageal and Gastric Varices (3)  ·  Hepatic Encephalopathy (3)  ·  Hepatitis, Autoimmune (3)  ·  Keloid (3)

Broader conditions

Pathologic Processes (82)  ·  Pathological Conditions, Signs and Symptoms (82)  ·  Digestive System Diseases (52)  ·  Liver Diseases (47)  ·  Infections (16)  ·  Virus Diseases (15)  ·  Hepatitis (14)  ·  Blood-Borne Infections (12)  ·  Communicable Diseases (12)  ·  Hepatitis, Viral, Human (12)  ·  DNA Virus Infections (9)  ·  Disease Attributes (9)  ·  Hepadnaviridae Infections (9)  ·  Chronic Disease (8)

Interventions

Propranolol (5)  ·  Carvedilol (4)  ·  Saline Solution (4)  ·  Nadroparin (3)  ·  Warfarin (3)  ·  entecavir (3)  ·  Amino Acids, Branched-Chain (2)  ·  Bleomycin (2)  ·  Botulinum Toxins, Type A (2)  ·  Cyclosporine (2)  ·  Glucocorticoids (2)  ·  Mycophenolic Acid (2)  ·  Pentoxifylline (2)  ·  Rifaximin (2)  ·  Simvastatin (2)

Sponsors

Shanghai Zhongshan Hospital (5)  ·  West China Hospital (4)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (3)  ·  Korea University (3)  ·  Shanghai Changzheng Hospital (3)  ·  Taipei Veterans General Hospital, Taiwan (3)  ·  Chang Gung Memorial Hospital (2)  ·  Hvidovre University Hospital (2)  ·  Peking Union Medical College Hospital (2)  ·  University of Cincinnati (2)  ·  Weill Medical College of Cornell University (2)  ·  All India Institute of Medical Sciences (1)  ·  Asian Institute Of Medical Sciences (1)  ·  Asian-Pacific Alliance of Liver Disease, Beijing (1)  ·  Assistance Publique - Hôpitaux de Paris (1)

Countries

China (24)  ·  South Korea (9)  ·  Spain (7)  ·  Taiwan (7)  ·  United States (6)  ·  Brazil (3)  ·  Denmark (3)  ·  Egypt (2)  ·  Israel (2)  ·  Mexico (2)  ·  Pakistan (2)  ·  Austria (1)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)

Top investigators

Shiyao Chen, Professor (5)  ·  Candido Villanueva, MD (2)  ·  Li Yang, MD (2)  ·  Ming-Chih Hou, MD (2)  ·  Robert P Baughman, MD (2)  ·  Soon Ho Um, Prof (2)  ·  Wei-Fen Xie, MD (2)  ·  Ahmad A Khairy, MD (1)  ·  Annette Dam, MD (1)  ·  Arnulf Ferlitsch, MD (1)  ·  Chuanwu Zhu, Doctor (1)  ·  Chun-Wei Lu, MD (1)  ·  Claudio Puoti, Prof (1)  ·  Cristina Manzanares-Cespedes, MD, PhD (1)

Results publications

PMID 19208350, PMID 10221490, PMID 10613747, PMID 10798738, PMID 11855555, PMID 11876689, PMID 12438948, PMID 12761269, PMID 14988829, PMID 15140214, PMID 15365369, PMID 15470215, PMID 15985009, PMID 16306522, PMID 16708058, PMID 17327353, PMID 17644502, PMID 19344721, PMID 20927486, PMID 23281973, PMID 23526308, PMID 24161699, PMID 24365449, PMID 24527306, PMID 25381721, PMID 26061491, PMID 26529126, PMID 28507927, PMID 28887164, PMID 30077741, PMID 30099397, PMID 30144521, PMID 32437567, PMID 32568867, PMID 33110280, PMID 33303216, PMID 33385299, PMID 33460002, PMID 33654016, PMID 33915943, PMID 34658014, PMID 34697111, PMID 34744427, PMID 34843068, PMID 34932836, PMID 37467180, PMID 38551983, PMID 41114449, PMID 41234032, PMID 41255102

NIH funding

2004 (1), 2014 (1), 2016 (1)